Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dietary Supplements | 45 | 2024 | 3294 | 9.030 |
Why?
|
Drug Contamination | 10 | 2024 | 148 | 3.470 |
Why?
|
United States Food and Drug Administration | 18 | 2022 | 1581 | 3.190 |
Why?
|
Consumer Product Safety | 7 | 2021 | 122 | 2.820 |
Why?
|
Legislation, Food | 4 | 2022 | 17 | 2.490 |
Why?
|
Anti-Obesity Agents | 7 | 2021 | 215 | 2.430 |
Why?
|
Amphetamines | 7 | 2021 | 148 | 2.260 |
Why?
|
Legislation, Drug | 4 | 2019 | 206 | 1.590 |
Why?
|
Drug Labeling | 3 | 2024 | 231 | 1.590 |
Why?
|
Drug Recalls | 3 | 2022 | 17 | 1.470 |
Why?
|
Central Nervous System Stimulants | 6 | 2021 | 1148 | 1.460 |
Why?
|
Cannabidiol | 2 | 2023 | 106 | 1.380 |
Why?
|
Amines | 4 | 2021 | 278 | 1.280 |
Why?
|
Drug Approval | 4 | 2019 | 740 | 1.140 |
Why?
|
Vinca Alkaloids | 2 | 2015 | 34 | 1.080 |
Why?
|
Piracetam | 2 | 2020 | 87 | 1.070 |
Why?
|
Government Regulation | 5 | 2019 | 522 | 1.070 |
Why?
|
Appetite Depressants | 4 | 2012 | 110 | 1.050 |
Why?
|
Chromatography, High Pressure Liquid | 8 | 2018 | 1574 | 1.050 |
Why?
|
Probiotics | 2 | 2019 | 351 | 1.020 |
Why?
|
Galantamine | 1 | 2024 | 32 | 0.960 |
Why?
|
Maleic Anhydrides | 2 | 2013 | 8 | 0.900 |
Why?
|
Meclofenoxate | 1 | 2022 | 1 | 0.890 |
Why?
|
Mucuna | 1 | 2022 | 6 | 0.890 |
Why?
|
Safety-Based Drug Withdrawals | 2 | 2013 | 38 | 0.880 |
Why?
|
Methanol | 1 | 2022 | 85 | 0.840 |
Why?
|
Tetrahydroisoquinolines | 2 | 2021 | 91 | 0.820 |
Why?
|
Ephedrine | 3 | 2021 | 54 | 0.790 |
Why?
|
Doping in Sports | 2 | 2018 | 63 | 0.790 |
Why?
|
Nootropic Agents | 2 | 2020 | 160 | 0.780 |
Why?
|
Alkaloids | 2 | 2021 | 190 | 0.780 |
Why?
|
Adrenergic Agonists | 1 | 2021 | 58 | 0.780 |
Why?
|
Housekeeping, Hospital | 1 | 2020 | 17 | 0.740 |
Why?
|
Sports | 3 | 2023 | 686 | 0.740 |
Why?
|
Health Facility Environment | 1 | 2020 | 34 | 0.730 |
Why?
|
Testosterone Congeners | 1 | 2020 | 62 | 0.700 |
Why?
|
Drugs, Generic | 1 | 2024 | 422 | 0.670 |
Why?
|
Product Labeling | 2 | 2015 | 79 | 0.630 |
Why?
|
Disinfection | 1 | 2020 | 191 | 0.630 |
Why?
|
Jurisprudence | 1 | 2018 | 109 | 0.610 |
Why?
|
United States | 32 | 2023 | 69693 | 0.610 |
Why?
|
Melatonin | 1 | 2023 | 720 | 0.600 |
Why?
|
Drug Industry | 3 | 2019 | 744 | 0.580 |
Why?
|
Biological Phenomena | 1 | 2016 | 28 | 0.570 |
Why?
|
Cannabis | 1 | 2023 | 432 | 0.570 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2021 | 633 | 0.560 |
Why?
|
Total Quality Management | 1 | 2018 | 274 | 0.560 |
Why?
|
Medical History Taking | 1 | 2020 | 783 | 0.550 |
Why?
|
Yohimbine | 1 | 2015 | 62 | 0.540 |
Why?
|
Acacia | 1 | 2015 | 2 | 0.530 |
Why?
|
Quality Control | 2 | 2018 | 841 | 0.530 |
Why?
|
Methamphetamine | 2 | 2014 | 152 | 0.510 |
Why?
|
Expert Testimony | 1 | 2018 | 356 | 0.510 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 276 | 0.500 |
Why?
|
Mass Spectrometry | 6 | 2018 | 2203 | 0.480 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1071 | 0.480 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2021 | 1123 | 0.470 |
Why?
|
Laboratories | 1 | 2018 | 461 | 0.470 |
Why?
|
Phytotherapy | 1 | 2016 | 298 | 0.460 |
Why?
|
Military Facilities | 1 | 2013 | 4 | 0.460 |
Why?
|
Plant Preparations | 2 | 2012 | 94 | 0.460 |
Why?
|
Micronutrients | 1 | 2016 | 375 | 0.440 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 535 | 0.440 |
Why?
|
Infection Control | 1 | 2020 | 962 | 0.430 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 959 | 0.430 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2013 | 101 | 0.430 |
Why?
|
Hyperlipidemias | 1 | 2017 | 786 | 0.420 |
Why?
|
Food Safety | 1 | 2011 | 22 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3130 | 0.410 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 390 | 0.410 |
Why?
|
Plant Extracts | 1 | 2015 | 469 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.410 |
Why?
|
Phentermine | 1 | 2011 | 33 | 0.400 |
Why?
|
Heart Rate | 2 | 2013 | 4091 | 0.390 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 496 | 0.380 |
Why?
|
Biological Products | 2 | 2017 | 856 | 0.380 |
Why?
|
Alcoholism | 1 | 2021 | 1904 | 0.380 |
Why?
|
Cross Infection | 1 | 2020 | 1413 | 0.380 |
Why?
|
Sulfones | 1 | 2013 | 437 | 0.380 |
Why?
|
Chlordiazepoxide | 1 | 2010 | 42 | 0.380 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2014 | 469 | 0.370 |
Why?
|
Pandemics | 3 | 2021 | 8328 | 0.370 |
Why?
|
Heptanes | 2 | 2021 | 8 | 0.360 |
Why?
|
Marketing | 1 | 2012 | 208 | 0.360 |
Why?
|
Self Medication | 1 | 2010 | 117 | 0.350 |
Why?
|
Caffeine | 2 | 2016 | 699 | 0.350 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 854 | 0.340 |
Why?
|
Fructose | 1 | 2011 | 288 | 0.340 |
Why?
|
Ambulatory Care | 1 | 2020 | 2706 | 0.330 |
Why?
|
Reference Standards | 4 | 2015 | 1020 | 0.320 |
Why?
|
Humans | 52 | 2023 | 742088 | 0.290 |
Why?
|
Blood Pressure | 2 | 2013 | 8541 | 0.290 |
Why?
|
Brazil | 5 | 2012 | 1263 | 0.290 |
Why?
|
Limit of Detection | 3 | 2016 | 264 | 0.280 |
Why?
|
Substance Abuse Detection | 1 | 2009 | 283 | 0.280 |
Why?
|
Fluoxetine | 1 | 2010 | 749 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3070 | 0.270 |
Why?
|
Organizations, Nonprofit | 1 | 2006 | 104 | 0.270 |
Why?
|
Cloning, Organism | 1 | 2005 | 54 | 0.260 |
Why?
|
Nuclear Transfer Techniques | 1 | 2005 | 64 | 0.260 |
Why?
|
Emigrants and Immigrants | 1 | 2011 | 519 | 0.250 |
Why?
|
Social Control, Formal | 1 | 2005 | 110 | 0.250 |
Why?
|
House Calls | 1 | 2006 | 159 | 0.250 |
Why?
|
Primary Prevention | 1 | 2012 | 1166 | 0.250 |
Why?
|
Octopamine | 2 | 2021 | 40 | 0.240 |
Why?
|
Weight Loss | 2 | 2012 | 2604 | 0.240 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 848 | 0.230 |
Why?
|
Dosage Forms | 1 | 2023 | 56 | 0.230 |
Why?
|
Vaccination | 1 | 2015 | 3256 | 0.230 |
Why?
|
Calcinosis | 1 | 2012 | 1497 | 0.220 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4250 | 0.220 |
Why?
|
Product Recalls and Withdrawals | 1 | 2022 | 7 | 0.220 |
Why?
|
Piperazines | 1 | 2013 | 2488 | 0.220 |
Why?
|
Powders | 1 | 2022 | 80 | 0.220 |
Why?
|
Models, Educational | 2 | 2012 | 377 | 0.210 |
Why?
|
Levodopa | 1 | 2022 | 218 | 0.200 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7901 | 0.200 |
Why?
|
Suicidal Ideation | 1 | 2011 | 1246 | 0.200 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 977 | 0.190 |
Why?
|
Anticonvulsants | 1 | 2011 | 1914 | 0.190 |
Why?
|
Prescription Drugs | 1 | 2007 | 595 | 0.190 |
Why?
|
Physician's Role | 1 | 2007 | 942 | 0.180 |
Why?
|
Synephrine | 2 | 2016 | 2 | 0.180 |
Why?
|
Poetry as Topic | 1 | 1999 | 17 | 0.170 |
Why?
|
History, 20th Century | 3 | 2012 | 2739 | 0.170 |
Why?
|
Clinical Clerkship | 2 | 2012 | 531 | 0.170 |
Why?
|
Exercise | 1 | 2015 | 5611 | 0.160 |
Why?
|
Students, Medical | 2 | 2012 | 1858 | 0.160 |
Why?
|
Attitude to Health | 1 | 2007 | 2051 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2012 | 3915 | 0.160 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7276 | 0.160 |
Why?
|
Communication | 4 | 2022 | 3728 | 0.160 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2015 | 361 | 0.150 |
Why?
|
Massachusetts | 5 | 2021 | 8662 | 0.150 |
Why?
|
Physiological Phenomena | 1 | 2016 | 18 | 0.140 |
Why?
|
Learning | 1 | 2006 | 1705 | 0.140 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7645 | 0.140 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 780 | 0.140 |
Why?
|
Pausinystalia | 1 | 2015 | 1 | 0.140 |
Why?
|
Camellia sinensis | 1 | 2015 | 8 | 0.130 |
Why?
|
Drug Combinations | 2 | 2011 | 1961 | 0.130 |
Why?
|
Administration, Oral | 1 | 2023 | 3913 | 0.130 |
Why?
|
Epilepsy | 1 | 2011 | 3301 | 0.130 |
Why?
|
Citrinin | 1 | 2014 | 1 | 0.130 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2014 | 22 | 0.130 |
Why?
|
Plant Leaves | 1 | 2015 | 143 | 0.130 |
Why?
|
Cyclobutanes | 2 | 2012 | 59 | 0.120 |
Why?
|
Lovastatin | 1 | 2014 | 120 | 0.120 |
Why?
|
Food Labeling | 1 | 2016 | 178 | 0.120 |
Why?
|
Food Inspection | 1 | 2012 | 3 | 0.110 |
Why?
|
Internship and Residency | 2 | 2006 | 5774 | 0.110 |
Why?
|
Obesity | 3 | 2011 | 12705 | 0.110 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 165 | 0.110 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6454 | 0.100 |
Why?
|
Phenolphthalein | 1 | 2011 | 5 | 0.100 |
Why?
|
Risk Assessment | 3 | 2021 | 23320 | 0.100 |
Why?
|
Morbidity | 1 | 2017 | 1767 | 0.100 |
Why?
|
Food Contamination | 1 | 2012 | 189 | 0.100 |
Why?
|
Spain | 1 | 2012 | 465 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 21596 | 0.100 |
Why?
|
Herb-Drug Interactions | 1 | 2010 | 10 | 0.100 |
Why?
|
Drug Evaluation | 1 | 2012 | 637 | 0.090 |
Why?
|
Purines | 1 | 2013 | 593 | 0.090 |
Why?
|
History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
Schools, Medical | 2 | 2012 | 878 | 0.090 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 459 | 0.090 |
Why?
|
Panic Disorder | 1 | 2012 | 616 | 0.080 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.080 |
Why?
|
Drug and Narcotic Control | 1 | 2009 | 146 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 2 | 2012 | 1004 | 0.080 |
Why?
|
Assisted Living Facilities | 1 | 2006 | 25 | 0.070 |
Why?
|
Tachycardia | 1 | 2009 | 620 | 0.070 |
Why?
|
History, 21st Century | 1 | 2012 | 1533 | 0.070 |
Why?
|
Clothing | 1 | 2006 | 92 | 0.070 |
Why?
|
Curriculum | 1 | 1999 | 3589 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2043 | 0.070 |
Why?
|
China | 1 | 2011 | 2246 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 1999 | 3839 | 0.060 |
Why?
|
Educational Measurement | 1 | 2012 | 1206 | 0.060 |
Why?
|
Cognition | 1 | 2022 | 6722 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12958 | 0.060 |
Why?
|
Culture Techniques | 1 | 2005 | 554 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1101 | 0.060 |
Why?
|
Female | 9 | 2016 | 379592 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2013 | 2050 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13256 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1053 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2014 | 2117 | 0.050 |
Why?
|
Primary Health Care | 1 | 1999 | 4551 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3239 | 0.050 |
Why?
|
Chest Pain | 1 | 2009 | 1113 | 0.050 |
Why?
|
Embryo Transfer | 1 | 2005 | 511 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10232 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2012 | 1912 | 0.050 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2009 | 997 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1423 | 0.040 |
Why?
|
Seizures | 1 | 2012 | 2851 | 0.040 |
Why?
|
Adult | 5 | 2011 | 213712 | 0.040 |
Why?
|
Teaching | 1 | 2006 | 1174 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3611 | 0.040 |
Why?
|
Women's Health | 1 | 2007 | 2034 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2275 | 0.040 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1284 | 0.040 |
Why?
|
Pseudoephedrine | 1 | 2016 | 4 | 0.040 |
Why?
|
Strychnine | 1 | 2016 | 33 | 0.040 |
Why?
|
Phenylpropanolamine | 1 | 2016 | 15 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3215 | 0.040 |
Why?
|
Comorbidity | 1 | 2011 | 10372 | 0.030 |
Why?
|
Program Evaluation | 2 | 2012 | 2485 | 0.030 |
Why?
|
Male | 5 | 2013 | 349538 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2015 | 223 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 932 | 0.030 |
Why?
|
Azo Compounds | 1 | 2014 | 113 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2014 | 235 | 0.030 |
Why?
|
Middle Aged | 3 | 2015 | 213127 | 0.030 |
Why?
|
Young Adult | 2 | 2011 | 56350 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35342 | 0.030 |
Why?
|
Electrophoresis, Capillary | 1 | 2012 | 64 | 0.030 |
Why?
|
Aged | 3 | 2021 | 162944 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20086 | 0.030 |
Why?
|
Laxatives | 1 | 2012 | 87 | 0.030 |
Why?
|
Calibration | 1 | 2014 | 815 | 0.030 |
Why?
|
Electric Conductivity | 1 | 2012 | 411 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2014 | 939 | 0.020 |
Why?
|
Mental Disorders | 1 | 2011 | 6587 | 0.020 |
Why?
|
Program Development | 1 | 2007 | 1314 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 24913 | 0.020 |
Why?
|
Anti-Anxiety Agents | 1 | 2012 | 390 | 0.020 |
Why?
|
Animals | 2 | 2012 | 168561 | 0.020 |
Why?
|
Risk Factors | 2 | 2021 | 72145 | 0.020 |
Why?
|
Diuretics | 1 | 2012 | 591 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19862 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5948 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 62966 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 29087 | 0.010 |
Why?
|
Child | 1 | 2011 | 77478 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8297 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 85649 | 0.010 |
Why?
|
Clinical Competence | 1 | 2007 | 4681 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2012 | 2838 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40054 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 77098 | 0.000 |
Why?
|
Concepts
(243)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_